Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP651195.RAdpX9i-gblQ2V9ninFjkMBZDWe6Tb2aCyGxkwl_uQ7oA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP651195.RAdpX9i-gblQ2V9ninFjkMBZDWe6Tb2aCyGxkwl_uQ7oA130_assertion type Assertion NP651195.RAdpX9i-gblQ2V9ninFjkMBZDWe6Tb2aCyGxkwl_uQ7oA130_head.
- NP651195.RAdpX9i-gblQ2V9ninFjkMBZDWe6Tb2aCyGxkwl_uQ7oA130_assertion description "[Our results provide first in vivo evidence for the molecular targeting therapeutic application of the K-ras repressor ESX1, especially TAT-mediated transduction of N-ESX1, in the treatment of human cancers having oncogenic K-ras mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651195.RAdpX9i-gblQ2V9ninFjkMBZDWe6Tb2aCyGxkwl_uQ7oA130_provenance.
- NP651195.RAdpX9i-gblQ2V9ninFjkMBZDWe6Tb2aCyGxkwl_uQ7oA130_assertion evidence source_evidence_literature NP651195.RAdpX9i-gblQ2V9ninFjkMBZDWe6Tb2aCyGxkwl_uQ7oA130_provenance.
- NP651195.RAdpX9i-gblQ2V9ninFjkMBZDWe6Tb2aCyGxkwl_uQ7oA130_assertion SIO_000772 18361917 NP651195.RAdpX9i-gblQ2V9ninFjkMBZDWe6Tb2aCyGxkwl_uQ7oA130_provenance.
- NP651195.RAdpX9i-gblQ2V9ninFjkMBZDWe6Tb2aCyGxkwl_uQ7oA130_assertion wasDerivedFrom befree-20140225 NP651195.RAdpX9i-gblQ2V9ninFjkMBZDWe6Tb2aCyGxkwl_uQ7oA130_provenance.
- NP651195.RAdpX9i-gblQ2V9ninFjkMBZDWe6Tb2aCyGxkwl_uQ7oA130_assertion wasGeneratedBy ECO_0000203 NP651195.RAdpX9i-gblQ2V9ninFjkMBZDWe6Tb2aCyGxkwl_uQ7oA130_provenance.